IM Cannabis (IMCC) Net Income towards Common Stockholders (2020 - 2026)

IM Cannabis (IMCC) recorded quarterly Net Income towards Common Stockholders of -$1.9 million in Q1 2026, up 67.05% quarter-over-quarter from -$5.6 million in Q4 2025, and down 2379.57% on a YoY basis from $81539.2 in Q1 2025.

IM Cannabis (IMCC) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

IM Cannabis' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$1.9 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 2379.57% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$6.0 million (down 63.21% YoY), while the FY2025 annual figure was -$8.1 million, down 4.99% from the prior year.
  • Net Income towards Common Stockholders was -$1.9 million for Q1 2026 at IM Cannabis, up from -$5.6 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $2.9 million in Q1 2022 to a low of -$94.8 million in Q3 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$9.0 million across 5 years, with a median of -$1.9 million in 2026.
  • The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders surged 492.52% in 2025, then slumped 2379.57% in 2026.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$17.5 million in 2022, then advanced by 29.04% to -$12.4 million in 2023, then soared by 93.02% to -$868325.0 in 2024, then tumbled by 549.6% to -$5.6 million in 2025, then surged by 67.05% to -$1.9 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$1.9 million (Q1 2026), -$5.6 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 366.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 IM Cannabis 57,090.22 -728,264.31 1.03 Mn -1.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.86 Mn
Dec 31, 2025 -5.64 Mn
Sep 30, 2025 2.65 Mn
Jun 30, 2025 -1.16 Mn
Mar 31, 2025 81,539.23
Dec 31, 2024 -868,325.01
Sep 30, 2024 -675,875.24
Jun 30, 2024 -2.21 Mn
Mar 31, 2024 -4.63 Mn
Dec 31, 2023 -12.44 Mn
Sep 30, 2023 1.59 Mn
Jun 30, 2023 -2.58 Mn
Mar 31, 2023 -640,577.05
Dec 31, 2022 -17.53 Mn
Sep 30, 2022 -94.80 Mn
Jun 30, 2022 -15.25 Mn
Mar 31, 2022 2.89 Mn
Dec 31, 2021 -3.27 Mn
Sep 30, 2021 -5.15 Mn
Jun 30, 2021 -3.77 Mn